A review on anti-inflammatory activity of phenylpropanoids found in essential oils

Molecules

Volumn 19, Issue 2, 2014, Pages 1459-1480

  Da Silveira E Sá, Rita De Cássia ^a   Andrade, Luciana Nalone ^b   De Oliveira, Rafael Dos Reis Barreto ^a   De Sousa, Damião Pergentino ^a,b  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Allergy; Anti inflammatory activity; Asthma; Cytokines; Essential oils; Immunomodulatory activity; Inflammation; Medicinal plants; Natural products; Phenylpropanoids

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL PRODUCT; CINNAMIC ACID; CINNAMIC ACID DERIVATIVE; CYTOKINE; ESSENTIAL OIL; PHENYLALANINE;

ASTHMA; CHEMISTRY; DRUG EFFECT; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; MEDICINAL PLANT; METABOLISM; PATHOLOGY; REVIEW;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BIOLOGICAL PRODUCTS; CINNAMATES; CYTOKINES; HUMANS; HYPERSENSITIVITY; IMMUNOMODULATION; INFLAMMATION; OILS, VOLATILE; PHENYLALANINE; PLANTS, MEDICINAL;

EID: 84894633536     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19021459     Document Type: Review

References (89)

1. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils-A review. Food Chem. Toxicol. 2008, 46, 446-475.
2. De Sousa, D.P. Medicinal Essential Oils: Chemical, Pharmacological and Therapeutic Aspects, 1st ed.; Nova Science Publishers: New York, NY, USA, 2012; p. 236.
3. Hahlbrock, K.; Scheel, D. Physiology and molecular biology of phenylpropanoid metabolism. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1989, 40, 347-369.
4. Friedrich, H. Phenylpropanoid constituents of essential oils. Lloydia 1976, 39, 1-7.
5. Ferrero-Miliani, L.; Nielsen, O.H.; Andersen, P.S.; Girardin, S.E. Chronic inflammation: Importance of NOD2 and NALP3 in interleukin-1beta generation. Clin. Exp. Immunol. 2007, 147, 227-235.
6. Abbas, A.B.; Lichtman, A.H. Innate Immunity. In Basic Immunology, Functions and Disorders of the Immune System, 3rd ed.; Abbas, A.B., Lichtman, A.H., Eds.; Elsevier: Amsterdam, The Netherlands, 2009.
7. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454, 428-435.
8. Barton, G.M. A calculated response: Control of inflammation by the innate immune system. J. Clin. Investig. 2008, 118, 413-420.
9. Saitoh, S.; Akashi, S.; Yamada, T.; Tanimura, N.; Kobayashi, M.; Konno, K. Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 2004, 16, 961-969.
10. Hopkins, S.J. The pathophysiological role of cytokines. Leg. Med. 2003, 5, S45-S57.
11. Vandekerckhove, F.; Opdenakker, G.; Vanranst, M.; Lenaerts, J.P.; Put, W.; Billiau, A.; van Damme, J. Bradykinin induces interleukin-6 and synergizes with interleukin-1. Lymphokine Cytokine Res. 1991, 10, 285-289.
12. Sá, R.C.S.; Andrade, L.N.; de Sousa, D.P. A review on anti-inflammatory activity of monoterpenes. Molecules 2013, 18, 1227-1254.
13. Lee, S.H.; Lee, S.Y.; Son, D.J.; Lee, H.; Yoo, H.S.; Song, S.; Oh, K.W.; Han, D.C.; Kwon, B.M.; Hong, J.T. Inhibitiory effect of 2'-hydroxycinnamaldehyde on nitric oxide production through inhibition of NF-kappaB activation in RAW 264.7 cells. Biochem. Pharmacol. 2005, 69, 791-799.
14. Kim, D.H.; Kim, C.H.; Kim, M.S.; Kim, J.Y.; Jung, K.J.; Chung, J.H.; An, W.G.; Lee, J.W.; Yu, B.P.; Chung, H.Y. Suppression of age-related inflammatory NF-kB activation by cinnamaldehyde. Biogerontology 2007, 8, 545-554.
15. Tung, Y.T.; Chua, M.T.; Wang, S.Y.; Chang, S.T. Anti-inflammation activities of essential oil and its constituents from indigenous cinnamon (Cinnamomum osmophloeum). Bioresour. Technol. 2008, 99, 3908-3912.
16. Chao, L.K.; Hua, K.F.; Hsu, H.Y.; Cheng, S.S.; Lin, I.F.; Chen, C.J.; Chen, S.T.; Chang, S.T. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food Chem. Toxicol. 2008, 46, 220-231.
17. Lin, S.S.C.; Lu, T.M.; Chao, P.C.; Lai, Y.Y.; Tsai, H.T.; Chen, C.S.; Lee, Y.P.; Chen, S.C.; Chou, M.C.; Yang, C.C. In vivo cytokine modulatory effects of cinnamaldehyde, the major constituent of leaf essential oil from Cinnamomum osmophloeum kaneh. Phytother. Res. 2011, 25, 1511-1518.
18. Yu, A.L.; Lu, C.Y.; Wang, T.S.; Tsai, C.W.; Liu, K.L.; Cheng, Y.P.; Chang, H.C.; Lii, C.K.; Chen, H.W. Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA.hy926 cells. J. Agric. Food Chem. 2010, 58, 7641-7648.
19. Ho, S.C.; Chang, K.S.; Chang, P.W. Inhibition of neuroinflammation by cinnamon and its main components. Food Chem. 2013, 138, 2275-2282.
20. Youn, H.S.; Lee, J.K.; Choi, Y.J.; Saitoh, S.I.; Miyake, K.; Hwang, D.H.; Lee, J.Y. Cinnamaldehyde suppresses toll-like receptor 4 activation mediated through the inhibition of receptor oligomerization. Biochem. Pharmacol. 2008, 75, 494-502.
21. Guo, J.Y.; Huo, H.R.; Zhao, B.S.; Liu, H.B.; Li, L.F.; Ma, Y.Y.; Guo, S.Y.; Jiang, T.L. Cinnamaldehyde reduces IL-1β-induced cyclooxygenase-2 activity in rat cerebral microvascular endothelial cells. Eur. J. Pharmacol. 2006, 537, 174-180.
22. Ballabeni, V.; Tognolini, M.; Giorgio, C.; Bertoni, S.; Bruni, R.; Barocelli, E. Ocotea quixos Lam. essential oil: In vitro and in vivo investigation on its anti-inflammatory properties. Fitoterapia 2010, 81, 289-295.
23. Kong, Y.H.; Lee, Y.C.; Choi, S.Y. Neuroprotective and anti-inflammatory effects of phenolic compounds in Panax ginseng CA Meyer. J. Ginseng. Res. 2009, 33, 111-114.
24. Kim, B.S.; Jeong, T.C.; Choe, S.Y.; Yang, K.H. Immunosuppressive effects of safrole in Balb/C mice. Korean J. Toxicol. 1993, 8, 191-203.
25. Parise-Filho, R.; Pastrello, M.; Camerlingo, C.E.P.; Silva, G.J.; Agostinho, L.A.; de Souza, T.; Magri, F.M.M.; Ribeiro, R.R.; Brandt, C.A.; Polli, M.C. The anti-inflammatory activity of dillapiole and some semisynthetic analogues. Pharm. Biol. 2011, 49, 1173-1179.
26. Dohi, T.; Terada, H.; Anamura, S.; Okamoto, H.; Tsujimoto, A. The anti-inflammatory effects of phenolic dental medicaments as determined by mouse ear edema assay. Jpn. J. Pharmacol. 1989, 49, 535-539.
27. Anamura, S. Effects of phenolic dental medications on arachidonic acid metabolism and their anti-inflammatory action. Hiroshima Daigaku Shigaku Zasshi 1989, 21, 147-162.
28. Koh, T.; Murakami, Y.; Tanaka, S.; Machino, M.; Sakagami, H. Re-evaluation of anti-inflammatory potential of eugenol in IL-1β-stimulated gingival fibroblast and pulp cells. In Vivo 2013, 27, 269-273.
29. Saeed, S.A.; Simjee, R.U.; Shamim, G.; Gllani, A.H. Eugenol: A dual inhibitor of platelet-activating factor and arachidonic acid metabolism. Phytomedicine 1995, 2, 23-28.
30. Chen, S.J.; Wang, M.H.; Chen, I.J. Antiplatelet and calcium inhibitory properties of eugenol and sodium eugenol acetate. Gen. Pharmacol. 1996, 27, 629-633.
31. Choi, Y.K.; Cho, G.S.; Hwang, S.; Kim, B.W.; Lim, J.H.; Lee, J.C.; Kim, H.C.; Kim, W.K.; Kim, Y.S. Methyleugenol reduces cerebral ischemic injury by suppression of oxidative injury and inflammation. Free Radic. Res. 2010, 44, 925-935.
32. Lee, J.Y.; Park, W. Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic-polycytidylic acid. Molecules 2011, 16, 7132-7142.
33. Hashimoto, K.; Yanagisawa, T.; Okui, Y.; Ikeya, Y.; Maruno, M.; Fujita, T. Studies on anti-allergic components in the roots of Asiasarum sieboldi. Planta Med. 1994, 60, 124-127.
34. Momin, R.A.; de Witt, D.L.; Nair, M.G. Inhibition of cyclooxygenase (COX) enzymes by compounds from Daucus carota L. Seeds. Phytother. Res. 2003, 17, 976-979.
35. Ritter, A.M.V.; Domiciano, T.P.; Verri, W.A.J.; Zarpelon, A.C.; da Silva, L.G.; Barbosa, C.P.; Natali, M.R.M.; Cuman, R.K.N.; Bersani-Amado, C.A. Antihypernociceptive activity of anethole in experimental inflammatory pain. Inflammopharmacology 2013, 21, 187-197.
36. Domiciano, T.P.; Dalalio, M.M.O.; Silva, E.L.; Ritter, A.M.V.; Estevão-Silva, C.F.; Ramos, F.; Caparroz-Assef, S.M.; Cuman, R.K.N.; Bersani-Amado, C.A. Inhibitory effect of anethole in nonimmune acute inflammation. Naunyn Schmiedebergs Arch. Pharmacol. 2013, 386, 331-338.
37. Kang, P.; Kim, K.Y.; Lee, H.S.; Min, S.S.; Seol, G.H. Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice. Life Sci. 2013, 93, 955-961.
38. Chi, T.; Ji, X.; Xia, M.; Rong, Y.; Qiu, F.; Zou, L. Effect of six extractions from Wuhu decoction on isolated tracheal smoothe muscle in Guinea pig. Zhongguo Shiyan Fangjixue Zazhi 2009, 15, 52-55.
39. Yu, B.P. Aging and oxidative stress: Modulation by dietary restriction. Free Radic. Biol. Med. 1996, 21, 651-668.
40. Shishodia, S.; Aggarwal, B.B. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates activation of cigarette smoke-induced nuclear factor (NF)-kappaB by suppressing activation of IkappaBalpha kinase in human non-small cell lung carcinoma: Correlation with suppression of cyclin D1, COX-2, and matrix metalloproteinase-9. Cancer Res. 2004, 64, 5004-5012.
41. Chung, H.Y.; Sung, B.; Jung, K.J.; Zou, Y.; Yu, B.P. The molecular inflammatory process in aging. Antioxid. Redox Signal. 2006, 8, 572-581.
42. Chang, S.T.; Chen, P.F.; Chang, S.C. Antibacterial activity of leaf essential oils and components from Cinnamomum osmophloeum. J. Ethnopharmacol. 2001, 77, 123-127.
43. Cheng, S.S.; Liu, J.Y.; Hsui, Y.R.; Chang, S.T. Chemical polymorphism and antifungal activity of essential oils from leaves of different provenances of indigenous cinnamom (Cinnamomum osmophloeum). Bioresour. Technol. 2006, 97, 306-312.
44. Chen, M.J.; Yang, Y.H.; Shieh, T.Y. Evaluation of a self-rating screening test for areca quid abusers in Taiwan. Public Health 2002, 116, 195-200.
45. Hsu, H.Y.; Wen, M.H. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 2002, 277, 22131-22139.
46. Dunn, D.E.; Herold, K.C.; Otten, G.R. Interleukin 2 and concanavalin A stimulate interferon-gamma production in a murine cytolytic cell clone by different pathways. J. Immunol. 1987, 139, 3942-3948.
47. Beissert, S.; Schwartz, A.; Schwarz, T. Regulatory T cells. J. Investig. Dermatol. 2006, 126, 15-24.
48. Kwon, H.K.; Hwang, J.S.; So, J.S.; Lee, C.G.; Sahoo, A.; Ryu, J.H. Cinnamon extract induces tumor cell death through inhibition of NF-jB and AP1. BMC Cancer 2010, 10, 392-401.
49. Liao, J.C.; Deng, J.S.; Chiu, C.S.; Hou, W.C.; Huang, S.S.; Shie, P.H.; Huang, G.J. Anti-inflammatory activities of Cinnamomum cassia constituents in vitro and in vivo. Evid. Based Complement. Alternat. Med. 2012, doi:10.1155/2012/429320.
50. Iiyama, K.; Hajra, L.; Iiyama, M.; Li, H.; DiChiara, M.; Medoff, B.D.; Cybulsky, M.I. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ. Res. 1999, 85, 199-207.
51. Glass, C.K.; Witztum, J.L. Atherosclerosis: The road ahead. Cell 2001, 104, 503-516.
52. Tak, P.P.; Firestein, G.S. NF-kappaB: A key role in inflammatory diseases. J. Clin. Investig. 2001, 107, 7-11.
53. Libby, P. Inflammation in atherosclerosis. Nature 2002, 420, 868-874.
54. Liao, B.C.; Hsieh, C.W.; Liu, Y.C.; Tzeng, T.T.; Sun, Y.W.; Wung, B.S. Cinnamaldehyde inhibits the tumor necrosis factor-α-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kB activation: Effects upon IkB and Nrf2. Toxicol. Appl. Pharmacol. 2008, 229, 161-171.
55. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140, 918-934.
56. Collins, S.E.; Noyce, R.S.; Mossman, K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J. Virol. 2004, 78, 1706-1717.
57. Lee, J.Y.; Hwang, D.H. The modulation of inflammatory gene expression by lipids: Mediation through Toll-like receptors. Mol. Cells 2006, 21, 174-185.
58. Uracz, W.; Uracz, D.; Olszanec, R.; Gryglewski, R.J. Interleukin 1beta induces functional prostaglandin E synthase in cultured human umbilical vein endothelial cells. J. Physiol. Pharmacol. 2002, 53, 643-654.
59. Sehic, E.; Szekely, M.; Ungar, A.L.; Oladehin, A.; Blatteis, C.M. Hypothalamic prostaglandin E2 during lipopolysaccharide-induced fever in guinea pigs. Brain Res. Bull. 1996, 39, 391-399.
60. Naranjo, P.; Kijjoa, A.; Giesbrecht, A.M.; Gottlieb, O.R. Ocotea quixos, American cinnamon. J. Ethnopharmacol. 1981, 4, 233-236.
61. Ballabeni, V.; Tognolini, M.; Bertoni, S.; Bruni, R.; Guerrini, A.; Rueda, G.M. Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador. Pharmacol. Res. 2007, 55, 23-30.
62. Kim, B.H.; Lee, Y.G.; Lee, J.; Lee, J.Y.; Cho, J.Y. Regulatory effect of cinnamaldehyde on monocyte/macrophage-mediated inflammatory responses. Mediat. Inflamm. 2010, doi:10.1155/2010/529359.
63. Samuelsson, B. Arachidonic acid metabolism: Role in inflammation. Z. Rheumatol. 1991, 50, 3-6.
64. Zhang, K.; Liu, C.; Kim, K.; Lee, S.Y.; Song, Y.; Jin, C.; Ryu, J.C.; Kim, M.; Park, J. Anti-inflammatory compounds inhibiting formation of leukotriene B4 in rat neutrophils. Environ. Mutagens Carcinog. 1994, 14, 34-42.
65. Yun, T.K. Brief introduction of Panax ginseng CA Meyer. J. Korean Med. Sci. 2001, 16, S3-S5.
66. Imamichi, T.; Nakamura, T.; Hayashi, K.; Kaneko, K.; Koyama, J. Different effects of cinnamic acid on the superoxide anion generation by guinea pig macrophages stimulated with a chemotactic peptide and immune complex. J. Pharmacobiodyn. 1990, 13, 344-352.
67. Ni, W.F.; Tsai, C.H.; Yang, S.F.; Chang, Y.C. Elevated expression of NF-kB in oral submucous fibrosis-Evidence for NF-kB induction by safrole in human buccal mucosal fibroblasts. Oral Oncol. 2007, 43, 557-562.
68. Pruthi, J.S. Species and Condiments, 1st ed.; National Book Trust: New Delhi, India, 1976; pp. 91-98.
69. Chainy, G.B.N.; Manna, S.K.; Chaturvedi, M.M.; Aggarwal, B.B. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: Effect on NF-kB, AP-1, JNK, MAPKK and apoptosis. Oncogene 2000, 19, 2943-2950.
70. Rasheed, A.; Laekeman, G.; Totte, J.; Vlietinck, A.J.; Herman, A.G. Eugenol and prostaglandin biosynthesis. N. Engl. J. Med. 1984, 310, 50-51.
71. 2+ mobilization and mitogen-activated protein kinases in Jurkat T-cells and monocytic THP-1 cells. Planta Med. 2005, 71, 634-639.
72. Singer, A.L.; Koretzky, G.A. Control of T cell function by positive and negative regulators. Science 2002, 296, 1639-1640.
73. Burhop, K.E.; Garcia, J.G.N.; Selig, W.M.; Lo, S.K.; Vander Zee, H.; Kaplam, J.E.; Malik, S.B. Platelet-activating factor increases lung vascular permeability to protein. Appl. Physiol. 1986, 61, 2210-2217.
74. Pollock, W.K.; Armstrong, R.A.; Brydon, L.J.; Jones, R.L.; Maclntyre, D.E. Thromboxane-induced phosphatidate formation in human platelets. Biochem. J. 1984, 219, 833-842.
75. Ahn, G.S.; Jang, H.U.; Jung, G.Y.; Kim, J.H.; Lee, H.G.; Lee, I.S.; Oh, S.R.; Park, S.H. Essential Oil Component Having Inhibition Activity of Leukotriene Production. Korea Patent 1020010086473, 12 September 2001.
76. Luster, M.I.; Simeonova, P.P.; Gallucci, R.M.; Matheson, J.M.; Yucesoy, B. Immunotoxicology: Role of inflammation in chemical-induced hepatotoxicity. Int. J. Immunopharmacol. 2000, 22, 1143-1147.
77. Yogalakshmi, B.; Viswanathan, P.; Anuradha, C.V. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 2010, 268, 204-212.
78. Ito, M.; Murakami, K.; Yoshino, M. Antioxidant action of eugenol compounds: Role of metal ion in inhibiton of lipid peroxidation. Food Chem. Toxicol. 2005, 43, 461-466.
79. Yano, S.; Suzuki, Y.; Yuzurihara, M.; Kase, Y.; Takeda, S.; Watanabe, S.; Aburada, M.; Miyamoto, K. Antinociceptive effect of methyeugenol on formalin-induced hyperlagesia in mice. Eur. J. Pharmacol. 2006, 553, 99-103.
80. Nishizawa, Y. Glutamate release and neuronal damage in ischemia. Life Sci. 2001, 69, 369-381.
81. Martins, C.; Doran, C.; Laires, A.; Rueff, J.; Rodrigues, A.S. Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells. Food Chem. Toxicol. 2011, 49, 385-392.
82. Narasimhan, B.; Dhake, A.S. Antibacterial principles from Myristica fragrans seeds. J. Med. Food 2006, 9, 395-399.
83. Cuschieri, J.; Maier, R.V. Oxidative stress, lipid rafts, and macrophage reprogramming. Antioxid. Redox. Signal. 2007, 9, 1485-1497.
84. Serhan, C.N.; Chiang, N.; van Dyke, T.E. Resolving inflammation: Dual anti-inflammatory and proresolution lipid mediators. Nat. Rev. Immunol. 2008, 8, 349-361.
85. Ishihara, K.; Hirano, T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine. Growth. Factor Rev. 2002, 13, 357-368.
86. Mallavarapu, G.R.; Ramesh, S. Composition of essential oils of nutmeg and mace. J. Med. Aromat. Plant Sci. 1998, 20, 746-748.
87. Radmark, O.P. The molecular biology and regulation of 5-lipoxygenase. Am. J. Respir. Crit. Care Med. 2000, 161, S11-S15.
88. Albert, D.; Zündorf, I.; Dingermann, T.; Müller, W.E.; Steinhilber, D.; Werz, O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem. Pharmacol. 2012, 15, 1767-1775.
89. De, M.; de, A.K.; Sen, P.; Banerjee, A.B. Antimicrobial properties of star anise (Illicium verum Hook f). Phytother. Res. 2002, 16, 94-95.